What is follistatin, and how does it influence hair follicle growth and regeneration?

Follistatin is a protein that naturally exists in the body. It was first identified for its role in regulating muscle development. What has drawn researchers to it more recently is its possible involvement in hair follicle regeneration. For anyone experiencing hair loss or looking beyond conventional treatments, it is worth understanding what follistatin is thought to do—and how little of that has been tested in people.

Follistatin binds and neutralises specific proteins that belong to the transforming growth factor-beta (TGF-β) superfamily. These include activin and myostatin, which regulate cell growth and differentiation. Laboratory work describes activin as able to inhibit follicular activity. When follistatin blocks activin, that inhibitory signal is interrupted, which is the proposed basis for reactivating follicles. This is a mechanism described in cell and animal biology, not a demonstrated treatment effect in people.

From Skin Cells to Scalp Revival: What Follistatin Does

To see why follistatin is discussed at all, it helps to look at how hair grows. Hair follicles cycle through a growth phase (anagen), a transitional phase (catagen), and a resting phase (telogen). In androgenetic alopecia—male or female pattern baldness—the anagen phase shortens and follicles miniaturise. Hair becomes thinner and is shed more readily.

Laboratory research describes follistatin as acting against some of the signals behind that process. It is reported to act at the bulge region of the follicle, where the stem cells involved in regeneration sit. By neutralising activin and related inhibitory proteins, follistatin is described as keeping those stem cells active in experimental systems, so follicles stay in a growth-supportive state longer than they otherwise would.

In cultured dermal papilla cells—the cells at the base of the follicle that regulate the hair cycle—follistatin has been reported to oppose signals associated with dihydrotestosterone (DHT), the hormone linked to follicle miniaturisation. In theory that could help sustain hair thickness. It is essential to read that as a laboratory finding: these effects have been studied in controlled cell systems and animal models, not in large human trials.

Hair Regeneration Through Genetic Expression

Follistatin is produced by the FST gene. Researchers have tried to raise follistatin activity through gene-therapy and topical approaches in animal studies. Some of these reported changes in hair density and follicle regeneration, and in dermal papilla cell work, higher follistatin levels have been associated with the upregulation of growth-related genes. Those are gene-expression readouts, which suggest a direction of effect rather than proving a hair outcome.

The reason this interests the hair-loss field is that some experimental therapies aim to raise follistatin at the scalp, with the goal of reactivating dormant follicles. There is also interest in whether the protein could help generate entirely new follicles—follicular neogenesis, a far more ambitious outcome. Early laboratory data of this kind should not be read as evidence of a cure.

What the Research Really Shows

Research into follistatin and hair growth is early, and most of it is preclinical. The studies most often cited in online discussions deserve a careful look, because several of them do not hold up.

The one human study that can be verified is a first-in-man phase 1 trial by Zimber and colleagues, published in the Journal of Drugs in Dermatology in 2011. It tested a single intradermal injection of a cell-conditioned medium containing Wnt proteins and follistatin in men with androgenetic alopecia, and reported increases in hair shaft thickness and terminal hair density. A phase 1 trial is designed primarily to look at safety in a small number of participants. It is a first signal, not proof of efficacy, and no larger controlled trial has followed it into routine use.

Several other studies circulate in follistatin discussions that could not be found in PubMed—including a frequently quoted 2012 topical-follistatin mouse experiment and a 2018 analysis of follistatin in cultured human dermal papilla cells. Because their existence cannot be confirmed, their numbers are not repeated here.

One real and relevant piece of background is Plikus and colleagues' 2008 paper in Nature, which showed that cyclic BMP signalling in the skin around the follicle governs when follicle stem cells activate: follicles enter the growth phase when that inhibitory signalling is low. Follistatin belongs to the same broad family of inhibitory-signal antagonists, which is why the paper is cited in this area. It is not a study of follistatin as a hair-loss treatment, and it was done in mice, whose synchronised hair cycles differ from the asynchronous cycles of human scalp.

Is Follistatin Ready for Clinical Use?

Follistatin is not approved by the U.S. Food and Drug Administration for treating hair loss, in any form. It is an experimental compound: there is no licensed follistatin medicine for hair, and how safe or effective it is on human scalps over months or years is unknown. Delivery is a real obstacle—raising follistatin throughout the body can interfere with other functions, including metabolic ones, so anything other than tightly targeted delivery carries risk.

Work continues on localised delivery, including topical, microneedling-assisted and injectable routes. Some groups are investigating smaller molecules intended to mimic follistatin's effect without genetic manipulation. None of these has an established safety record in people.

For anyone losing hair now, follistatin is a possible future treatment, not a present-day one. Current findings are early steps in a long research path rather than clinical answers. Its biology is genuinely interesting; clinical validation is still missing.

Talk to a doctor or pharmacist before starting, stopping or combining any hair-loss treatment, and before considering any injectable or research compound such as follistatin. Products sold online claiming to contain follistatin are unregulated, are not approved medicines, and their contents and long-term safety are unknown.

Conclusion: What We Need to Know

Follistatin interacts with proteins that suppress hair follicle activity, and blocking those signals is the proposed route to a more growth-favourable environment. Animal and laboratory studies suggest it can help maintain the growth phase, and a single small phase 1 human trial of a Wnt-and-follistatin injection reported thicker hair shafts and higher terminal hair density. None of this has been confirmed in large-scale human trials.

For anyone looking for a treatment to act on today, follistatin is not clinically proven. Its promise is still in laboratories rather than dermatology clinics. Understanding the mechanism helps readers judge the claims they meet, and it is also a reason to be wary of unapproved products that claim to contain follistatin.

User Experiences with Follistatin for Hair Growth and Regeneration

Follistatin comes up periodically in the Tressless community, mostly among users looking at alternatives or adjuncts to Minoxidil and Finasteride. Originally known for inhibiting myostatin and promoting muscle growth in animal studies, it is now discussed for its possible effects on hair follicle cycling.

Community posts point to studies suggesting follistatin counteracts activin, a TGF-β superfamily protein described as inhibiting follicle growth. Posters describe follistatin as binding activin and blocking that signal, and so extending the anagen phase. That is the mechanism proposed in preclinical work, and it is what has driven the interest.

One community post refers to injections of follistatin and growth factors—combined with Wnt proteins—improving hair density and thickness. That post is pointing at a real study: the 2011 phase 1 trial described above, in which a single intradermal injection of a Wnt- and follistatin-containing treatment was reported to increase hair shaft thickness and terminal hair density in men with androgenetic alopecia. It drew attention from users looking beyond the standard "Big 4" treatments, particularly those who felt they had plateaued. A phase 1 result in a small group is not a basis for treatment decisions.

User sentiment also includes caution. Commenters note the absence of large, long-term human studies of follistatin for hair loss, and raise concerns about access, regulatory status and cost. A recurring theme is frustration that promising compounds stay confined to experimental settings while over-the-counter options remain limited.

Other users speculate about combining follistatin-based therapies with microneedling or topical finasteride. Such combinations have not been clinically tested, and neither their effect nor their safety is known. There is also discussion of gene-therapy approaches and of hypothetical future transdermal products.

Overall, follistatin sits at an early stage of clinical exploration while generating optimism among users looking for new approaches. It is one of several growth-factor pathways the community watches, and it remains experimental rather than available.

References

Zimber, M. P., Ziering, C., Zeigler, F., Hubka, M., & Mansbridge, J. N. (2011). Hair regrowth following a Wnt- and follistatin containing treatment: safety and efficacy in a first-in-man phase 1 clinical trial. Journal of Drugs in Dermatology, 10(11), 1308–1312. PMID: 22052313. https://pubmed.ncbi.nlm.nih.gov/22052313/

Plikus, M. V., Mayer, J. A., de la Cruz, D., Baker, R. E., Maini, P. K., Maxson, R., & Chuong, C. M. (2008). Cyclic dermal BMP signalling regulates stem cell activation during hair regeneration. Nature, 451(7176), 340–344. PMID: 18202659. https://www.nature.com/articles/nature06457

U.S. National Institutes of Health. (2022). Hair Loss: Overview. MedlinePlus. https://medlineplus.gov/hairloss.html

U.S. Food and Drug Administration. (2023). Drug Development and Approval Process. https://www.fda.gov/drugs/development-approval-process-drugs

Reddit user. Follistatin — thoughts about a potential treatment. https://reddit.com/r/tressless/comments/16f1m6n/follistatin_thoughts_about_a_potential_treatment/

Reddit user. Injections of follistatin and growth factors. https://reddit.com/r/tressless/comments/ud92t/injections_of_follistatin_and_growth_factors/

Reddit user. Hair regrowth following a Wnt and follistatin treatment. https://reddit.com/r/tressless/comments/27aycv/hair_regrowth_following_a_wnt_and_follistatin/